EXPLORING THE PHARMACOLOGICAL PROFILES OF BENZIMIDAZOLE DERIVATIVES: A COMPREHENSIVE REVIEW

Palani, Shanmugasundaram and Balakrishnan, Vijay Sheela and Dubey, Vaishnavi and Muthukumaran, Vishwa and Indhumathy, Pugazhendhi (2026) EXPLORING THE PHARMACOLOGICAL PROFILES OF BENZIMIDAZOLE DERIVATIVES: A COMPREHENSIVE REVIEW. Current Topics in Medicinal Chemistry, 26. ISSN 15680266

Full text not available from this repository. (Request a copy)

Abstract

EXPLORING THE PHARMACOLOGICAL PROFILES OF BENZIMIDAZOLE DERIVATIVES: A COMPREHENSIVE REVIEW Shanmugasundaram Palani https://orcid.org/0000-0003-2961-0665 Vijay Sheela Balakrishnan https://orcid.org/0009-0009-2773-5238 Vaishnavi Dubey Vishwa Muthukumaran https://orcid.org/0009-0006-5432-3755 Indhumathy Pugazhendhi https://orcid.org/0000-0003-4080-7178 Abstract:

Fused heterocyclic scaffolds appear to be the most developing topic in therapeutic chemistry, especially benzimidazole, is a bicyclic compound consisting of a benzene ring fused to an imidazole ring and found in the tissues of plants and animals (including histidine, purines, and vitamin B12). Also, it plays an important structural role in the preparation of bioactive compounds. Derivatives of benzimidazole have shown therapeutic activity in various applications, including anthelmintic, anti-inflammatory, anticancer, antimicrobial, and antiulcer. The physicochemical properties of benzimidazole have evolved to promote this activity mainly because of their favourable physical features and their ability to function on several functional biological targets. They include hydrogen bonding, π–π stacking, and hydrophobic interactions. More recently, molecular docking studies with their binding affinity and mechanism of action have become known, which further contributes to the rational design of novel drugs. Derivatives of benzimidazole seem to hold considerable potential for multitargeted therapeutic strategies. In this review, we offer an overview of the chemistry, latest biological activities, design techniques, and structure–activity relationship (SAR) data of several analogues derived from benzimidazole.
03 04 2026 LiveAll1 1 10.2174/BSP_crossmark_policy eurekaselect.com true Peer Reviewed Double blind Checked with iThenticate 2025-07-29 2025-10-21 2025-10-24 2026-03-04 10.2174/0115680266425342260112130801 https://www.eurekaselect.com/250487/article https://www.eurekaselect.com/250487/article https://www.eurekaselect.com/article/download?doi=10.2174/0115680266425342260112130801 https://www.eurekaselect.com/article/download?doi=10.2174/0115680266425342260112130801 https://www.eurekaselect.com/article/download?doi=10.2174/0115680266425342260112130801 https://www.eurekaselect.com/article/download?doi=10.2174/0115680266425342260112130801 https://www.eurekaselect.com/article/download?doi=10.2174/0115680266425342260112130801 https://www.eurekaselect.com/article/download?doi=10.2174/0115680266425342260112130801 https://www.eurekaselect.com/250487/article

Item Type: Article
Subjects: Pharmaceutical Chemistry and Analysis > Pharmaceutical Chemistry
Domains: Pharmaceutical Chemistry and Analysis
Depositing User: Mr IR Admin
Date Deposited: 09 May 2026 10:04
Last Modified: 09 May 2026 10:04
URI: https://ir.vistas.ac.in/id/eprint/14344

Actions (login required)

View Item
View Item